Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma
Margaretha G.M. Roemer(Amsterdam University Medical Centers), Margaret A. Shipp(Broad Institute)
Cited by 366
Related Papers
Targetable genetic features of primary testicular and primary central nervous system lymphomas
|Blood|2015|597
Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma
|Blood|2017|332
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation
|Blood|2019|187
BAL1 and Its Partner E3 Ligase, BBAP, Link Poly(ADP-Ribose) Activation, Ubiquitylation, and Double-Strand DNA Repair Independent of ATM, MDC1, and RNF8
|Molecular and Cellular Biology|2012|115